to investigate prognostic significance of many factors in MDS including HALP score ( haemoglobin level, albumin level, lymphocyte, platelets), monocytopenia, hyperfibrinogenemia and AST/ALT ratio in patients with MDS at Assiut University Hospital.
And to study overall survival and leukemia free survival rates in MDS patients.
• Adults (≥18 years old) diagnosed with MDS according to WHO criteria
Availability of complete medical records including laboratory data for hemoglobin, albumin, lymphocyte count, platelet count, monocyte count, fibrinogen level, AST and ALT
Patients who were followed for at least 12 months post-diagnosis or until death
Patients with active infections, liver cirrhosis, chronic inflammatory diseases, or concurrent malignancies at time of diagnosis
Incomplete laboratory or clinical data
Patients lost to follow-up within less than 3 months of diagnosis
Adults (≥18 years old) diagnosed with MDS according to WHO criteria
Other
Cross-sectional
Not listed
prognostic significance of many factors in MDS
to investigate prognostic significance of many factors in MDS including HALP score ( haemoglobin level, albumin level, lymphocyte, platelets), in patients with MDS at Assiut University Hospital HALP : a derived value from a formula: Hemoglobin (g/L) × Albumin (g/L) × Lymphocytes (/L) / Platelets (/L)
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
